Objective To evaluate the relationship of the presenting features of acute coronary syndrome (ACS) to inhospital adverse events (total and cardiac deaths, heart failure and serious dysrhythmia) and the effects of coronary intervention. Background Patients with ACS may present with dyspnea, shock and/or cardiac arrest with or without accompanying chest pain. Methods We evaluated 9,373 patients (age 65±12 years and 60% males) enrolled in the Thai ACS Registry. Cardiac dyspnea included shortness of breath on exertion, and/or at rest, orthopnea, or paroxysmal nocturnal dyspnea presumed from cardiac sources. Shock was present if systolic blood pressure was <90 mmHg for >30 min with symptoms of end-organ hypoperfusion. Post cardiac arrest was identified if cardiopulmonary resuscitation was required. We calculated the frequencies of these presenting features and assessed their contribution toward in-hospital adverse events (total and cardiac deaths, heart failure and serious arrhythmias) for the whole ACS and each entity of ACS and the effects of in-hospital interventions, both coronary and medicinal. Results Cardiac dyspnea, shock and post cardiac arrest were seen in 32. 7%, 9.3%, and 4.2% of patients, respectively. In-hospital adverse events occurred more frequently in patients with these presenting features than those without (p<0.05). Cardiac dyspnea and shock were independent predictors of heart failure and death, respectively, while post cardiac arrest independently identified patients at risk of arrhythmia, total and cardiac death, regardless of the subgroup of ACS. Coronary revascularization significantly reduced the risk of total and cardiac death. Conclusion These 3 presenting features of ACS portend a poor prognosis, regardless of the subgroup of ACS and should be considered as important early indicators for early intervention.
Introduction
Coronary artery disease is a major cause of morbidity and mortality worldwide. Acute coronary syndrome (ACS), which covers ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI) , and unstable angina (UA), is one of the lifethreatening manifestations of coronary artery disease. The final outcome varies depending on the characteristics of the patient, the subset of ACS, and the newer modalities of intervention (1, 2) . To alter the outcome, appropriate selection of subjects for coronary intervention is vital and one of the ways to achieve this is risk stratification. A facet of risk stratification is the presenting features accompanying chest pain, this being the hallmark of presentation of ACS (3). Silent or atypical presentations of ACS have been reported in 8-52% of patients with ACS and are associated with less effective management and unfavorable prognosis (4) (5) (6) (7) (8) (9) . Dyspnea, presyncope/syncope, nausea/vomiting and cardiac arrest are common among atypical presentations of ACS and have previously been studied as a group in predicting adverse outcomes (4, 5, 7, 8) , but not separately. However, several presenting features of ACS (eg. shock) are not commonly stressed, possibly because of potential overlap with in-hospital outcomes (e.g. shock at presentation vs. developed shock) . The recently completed ACS registry in selected hospitals in Thailand separated these features at entry. Hence, the objectives of the study were to evaluate the relationship of cardiac dyspnea, shock and post cardiac resuscitation to in-hospital adverse outcomes and the effects of coronary interventions such that the alterations of outcomes can be shown.
Methods

Study population
Hospitalized patients with a presumptive diagnosis of ACS at presentation from 17 hospitals in Thailand were prospectively enrolled in the Thai ACS Registry from August 2002 to October 2005 The study was approved by the local ethical committee of each participating hospital. Series workshops were organized to standardize and control the quality of data and the conduction of the study. Patients had to be !18 years of age and had symptoms consistent with ACS accompanied by electrocardiographic changes. All cases were further classified, using electrocardiographic criteria and cardiac biochemical markers, to one of the following discharge diagnoses: STEMI, NSTEMI, or 
Presenting features
The presenting features of ACS used in this study consisted of cardiac dyspnea, shock and post cardiac arrest. Dyspnea had to be cardiac in origin which included shortness of breath on exertion and/or at rest, orthopnea, or paroxysmal nocturnal dyspnea. Shock was deemed to be present if the systolic blood pressure was <90 mmHg for >30 minutes and associated with symptoms of end-organ hypoperfusion. Post cardiac arrest implied patients who had been resuscitated from a cardiac arrest which was most likely to have originated from an ACS. The resuscitation could be at another hospital or at the admitting hospital.
In-hospital adverse events
The adverse events in this study were death (total and cardiac), heart failure, serious arrhythmias, stroke, and major bleeding. Total death included both cardiac-and noncardiacrelated causes; the cardiac-related included death from pump failure, mechanical complications or arrhythmias. In-hospital heart failure was defined as Killip's class 2 or above. Serious arrhythmias consisted of second or third degree atrioventricular block, sustained ventricular tachycardia or ventricular fibrillation. Stroke was defined as a sudden neurological deficit from a cerebral cause with a residual deficit of at least 24 hours after the onset. Major bleeding was documented if there was overt clinical bleeding requiring a blood transfusion or bleeding associated with a decrease in hemoglobin of !5 g/dL or hematocrit of !15%. Intracranial or retroperitoneal hemorrhage was also considered major bleeding.
Statistical analysis
The presenting features were evaluated with reference to the major in-hospital adverse events for the whole ACS as well as for each of the 3 components of ACS. Categorical variables were summarized as percent (%) of patients, and continuous variables as mean ± standard deviation. Comparison between groups was based on the Wilcoxon ranksum test for continuous variables and Pearson's chi-square test for categorical variables. Multivariable associations of clinical characteristics, presenting features and treatment variables with total and cardiac deaths were assessed. We used the Cox proportional hazard model since the time of in-hospital death was known. Logistic regression was used to assess the multivariable associations of those with heart Variables were selected in a stepwise forward selection manner with entry and retention set at a significance level of 0.05. Results of these analyses were summarized as odds ratios or hazard ratios with 95% confidence intervals.
Results
There were 9,373 patients enrolled in the Thai ACS Registry. The distribution of discharge diagnoses of STEMI, NSTEMI and UA was 41%, 38%, and 21%, respectively. The mean age was 65.2±12.3 years, 60% were males, 40% were referred, and 75% were classified as having dyslipidemia, 64% hypertensive, 44% diabetes mellitus, 22% current smoker, and 9% having a family history of premature coronary artery disease. The frequencies of the presenting features and chest pain are shown in Table 1 . All 3 presenting features coexisted in 0.9% of patients, regardless of the presence of chest pain. Thirty-nine percent had at least one of the 3 presenting features. Patients without chest pain, as compared to those with chest pain, were more likely to present with shock (19% vs. 8%), post cardiac arrest (14% vs. 3%) and cardiac dyspnea (72% vs. 29%) (p<0.0001 for all of the presenting features). The use of aspirin, statin, angiotensin-converting enzyme inhibitor and/or angiotensin II receptor blocker and beta-blocker as in-hospital medications were reported in 95, 80, 63 and 62% of patients, respectively. Among 3,836 patients with STEMI, 30% received thrombolytic therapy. Percutaneous coronary intervention and coronary bypass surgery were performed in 45% and 6% of patients with STEMI and in 20% and 7% of patients with NSTEMI plus UA, respectively.
Outcomes
The median length of hospital stay was 6.8 days (interquartile range 3.9-11.9 days) and was not significantly different in patients with shock or post cardiac arrest as compared to those without. For the whole registry, in-hospital heart failure occurred in 45.1%; serious arrhythmias in 16.6%, total death in 12.6%, cardiac death in 9.8%, major bleedings in 5.9%, and stroke in 2.0% of patients. Table 2 shows selected in-hospital adverse events (total and cardiac death, heart failure, serious arrhythmias) in patients with each of the 3 presenting features as compared to those without. All adverse events were significantly higher in patients with the presenting features, regardless of the types of ACS. Shock and post cardiac arrest increased event rates by 3-6 times. Presence of cardiac dyspnea increased risk of death and in-hospital heart failure by 2-3 times. The rate of inhospital heart failure, even in the absence of presenting cardiac dyspnea, was very high (26% for the whole ACS registry and 30% for those with myocardial infarction). Table 3 shows selected variables from the Kaplan-Meier analysis of total and cardiac death. Shock and post cardiac arrest, but not cardiac dyspnea, were independent predictors, while coronary revascularization significantly improved these outcomes. 
Predictors of in-hospital adverse events
T a b l e 3 . Mu l t i v a r i a t e P r e d i c t o r s o f T o t a l a n d Ca r d i a c De a t h a c c o r d i n g t o t h e Di s c h a r g e Di a g n o s e s
of heart failure and serious arrhythmias (range of odds ratios 0.4-0.6), regardless of the subgroups of ACS (data not shown). Data are expressed as odds ratio (95% confidence interval). Table 3 .
Abbreviations as in
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Discussion
The frequency of the 3 presenting features (cardiac dyspnea, shock and post cardiac arrest) in the Thai ACS registry depended on the presence of the accompanying chest pain. This distinction (i.e. accompanying chest pain) is important when the prevalence of such topics is reported. Cardiac dyspnea, shock and post cardiac arrest were significantly more prevalent in patients without chest pain than in those with chest pain. As shown in Table 2 , each of these presenting features was associated with very high rates of in-hospital adverse outcomes in terms of death, heart failure and serious arrhythmias. In the following discussion, we will show evidence that these presenting features of ACS should be used as indicators towards more aggressive coronary intervention.
Shock at presentation of ACS may manifest differently from shock that developed during the hospital stay. This has been reported to have a higher overall in-hospital mortality than those with delayed shock (75% vs. 56%, p<0 .001) and reportedly represents 20% of all cardiogenic shock complicating acute myocardial infarction with left ventricular dysfunction (10). In the present study, the frequency of shock at presentation was very high, 16.3% in patients with STEMI and 4.5% in those with NSTEMI combined with UA, in contrast to 2.5% of patients with STEMI from the National Registry of Myocardial Infarction (11) . The high prevalence of cardiogenic shock in our registry may be due to the relatively high prevalence of diabetes mellitus (44%). This high prevalence of diabetes in shock patients had also been reported in other ACS patients (10) (11) (12) . In contrast to the high prevalence of shock at presentation, the overall in-hospital mortality among STEMI patients who presented with cardio-genic shock in our registry (43.4%) was not much different from that in the National Registry of Myocardial Infarction (47.9%) (11). This suggests that the mortality among our patients who presented with shock may not be related to delayed admission or lack of intervention. Fifty-six percent of our STEMI patients arrived within 12 hours of symptom onset and 66.5% received some forms of reperfusion. The present analysis showed that shock at presentation was an independent predictor of death for the whole ACS and for each subset, while coronary revascularization was a negative predictor of death. However, analysis of the registry cannot offer a firm conclusion regarding a direct relationship between shock and the benefit of coronary intervention. Reports from the SHOCK registry and trial have shown that emergency coronary revascularization, as compared to initial medical stabilization, significantly improved overall survival in patients with cardiogenic shock complicating acute myocardial infarction at 6 months (13) and up to 2 years (14), following which the slopes for mortality rates paralleled. Shock at presentation showed a similar decrease in mortality with coronary revascularization (10). Since early coronary intervention has been proven to reduce in-hospital mortality, it is strongly suggested that shock, even at presentation, of ACS, should be regarded as an indicator for immediate intervention.
Cardiac arrest is an unusual presenting symptom of ACS and its frequency varies from 1.0% to 10.5% of patients across all spectra of ACS patients (5, 7, 8) as compared to 4.2% in the present study where 71% of patients with cardiac arrest had STEMI. In one study, patients presenting with cardiac arrest had a high proportion (71%) of significant coronary artery disease on angiography (15), while in another, 80% of STEMI patients with resuscitated cardiac arrest had thrombus-containing lesion (16) . The presence of cardiac arrest at presentation increased the risk of adverse cardiac and cerebral events (17) , which may be due to missed or delayed diagnosis of ACS and/or less aggressive treatment after cardiopulmonary resuscitation. In the present registry, 41.5% and 50.1% of patients who presented with cardiac arrest suffered cardiac and total death, respectively, values similar to those who presented with shock. Data on the potential benefit of early coronary reperfusion therapy in resuscitated patients after cardiac arrest complicating ACS are mainly suggestive. Recent trials have suggested that thrombolysis during out-of-hospital cardiopulmonary resuscitation may be beneficial without the anticipated excess bleeding (18, 19) . Reports on percutaneous coronary intervention after post cardiac resuscitation are sparse and purely observational. The benefit of percutaneous coronary intervention in ACS patients who survived out-of-hospital cardiac arrest depends on the factors related to cardiac arrest (such as being witnessed, promptness of resuscitation, physical and mental conditions after resuscitation (20) , and time elapsed prior to intervention). Successful revascularization could be associated with the in-hospital survivals of 100% (20), 6-month survivals of 54%, and free of neurological deficit (16) . Even those who were unconscious during percutaneous coronary intervention had in-hospital and 6-month survivals of 57% and 26%, respectively. Spaulding et al reported that successful percutaneous coronary intervention is one of the multivariate factors for survival (15) . It is unlikely that there will be a large randomized double-blind trial to verify the superiority of percutaneous coronary intervention in ACS patients resuscitated from cardiac arrest. Since coronary occlusion is common in patients who had sustained cardiac arrest outside of the hospital (15, 16) , it is suggested that immediate percutaneous coronary intervention should be instituted even for those with delayed cardiopulmonary resuscitation or comatose patients.
Presenting cardiac dyspnea was observed in one-third of patients in the present study. Frequencies of presenting cardiac dyspnea in the literatures show a wide range of 17% to 70% (4, 5, 7, 8) , perhaps depending on the definition of dyspnea used in each study (e.g. Killip's criteria) and the population selected. The total and cardiac deaths among those who presented with cardiac dyspnea in the present study were 20% and 15%, respectively. Our cardiac dyspnea patients included those with shock and/or post cardiac arrest. This may be a partial explanation of why dyspnea, as our presenting symptom, was not an independent predictor of death, in contrast to other reports (21-23) whose subjects may have much lower incidences of shock and arrest. Excluding death, our analysis, as expected, showed that cardiac dyspnea at presentation was an independent predictor of heart failure and 85% of these patients continued toward inhospital heart failure as compared to a 26% heart failure rate among those without cardiac dyspnea at presentation (Table 2). There is no large randomized controlled trial evaluating the beneficial effect of coronary revascularization in preventing heart failure among ACS patients who present with cardiac dyspnea. Steg et al found that among ACS patients presenting with Killip 2 and 3 and who received in-hospital revascularization, there was a lower 6-month mortality rate of 14.0% vs. 23.7% among those without intervention (hazard ratio 0.5, . Hence, we conclude that cardiac dyspnea at presentation of ACS often persists to heart failure with its associated high mortality. Several reports have shown that a proportion of patients with ACS and heart failure do not receive appropriate medication (22) (23) (24) . This should be corrected and such patients should possibly receive early coronary revascularization to prevent the development of heart failure and to reduce mortality.
Study limitations
The common limitation of registries is that data are obtained from medical records, which may depend on a further interpretation by the study coordinators who may be physicians. Secondly, any registry, by both design and constraints, is bounded by a limited number of variables. The present registry did not have data on a previous history of heart failure or previous myocardial infarction; this precludes more accurate factors related to both presenting features and/or inhospital outcomes. In the present analysis, we did not have data on grades of severity of presenting features such as Killip's classification, echocardiography, natiuretic peptide, mental status after resuscitation or duration of shock, and thus, this does not allow the analyses to lead to the mechanisms.
Conclusion
Three presenting features (shock, post cardiac arrest and cardiac dyspnea) aside from chest pain were common in the Thai ACS registry. These features were closely related to high in-hospital adverse outcomes (total and cardiac deaths, heart failure and serious arrhythmias). Hence, it is strongly recommended that these presentations of ACS are regarded as indicators for prompt treatment and aggressive coronary intervention.
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